Cresols Market Size is forecast to exceed $474 million by

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cresols Market Size is forecast to exceed $474 million by 2024: Global Market Insights, Inc.

Ocean View, Delaware, Oct. 12, 2016 (GLOBE NEWSWIRE) --

Cresols Market size is forecast to exceed USD 474 million by 2024; according to a new research report by Global Market Insights, Inc.

Increasing vitamin demand in food & beverage fortification and dietary supplements will boost global cresols market size by 2024. Robust dietary supplement demand is chiefly driven by unbalanced food nutrition adulteration coupled with improving consumer food habits and lifestyles.

In 2015, world-wide synthetic vitamin E intake was approximately 100 kilo tons and might surpass 150 kilo tons in coming years, at over 4% CAGR. Furthermore, rising meat consumption and synthetic vitamin E will result in growth of animal feed and feed additives, that will in turn drive growth by 2024. Increasing nutraceutical demand, as a result of rising consumer awareness regarding improved nutrient intake, will also favor industry growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/789

Butylated hydroxytoluene (BHT) is useful in food & beverage applications due to its antioxidant characteristics, which makes it preferred to stabilize fats and to retain color, flavor and aroma. BHT is used as an antioxidant in gum, cereals, processed potatoes, fast food, snack foods and drink mixes. In addition, it is used in pharmaceuticals, cosmetics, food packaging, plastics and rubber. However, BHT more than over 0.02% concentration in the food additive is categorized as GRAS by the FDA, as its excessive consumption is injurious and may damage lungs, kidneys and livers. Furthermore, countries including Romania, Japan, Australia and Sweden have banned the product use in food & beverage which may negatively influence cresols market share during future years.

Global cresols market share has a notable application in electrical & electronics and automotive sector owing to its capability to endure high temperature under mechanical stress with less bend or creep. The mentioned characteristics makes the product ideal in automotive brake pistons, pulleys and natural gas valves. This as a result, has opened new growth opportunities for cresols market from 2016 to 2024.

Browse key industry insights spread across 90 pages with 146 market data tables & 12 figures & charts from the report , “Cresols Market Size By Product (Meta-Cresols, Para-Cresols, Ortho-Cresols), By Application (Chemical Intermediates, Solvents, Preservatives, Antioxidants), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, India, Japan, Australia, Indonesia, Malaysia, Brazil, Mexico, South Africa, GCC), Application Potential, Price Trends, Competitive Market Share & Forecast, 2013 – 2024” in detail along with the table of contents :

https://www.gminsights.com/industry-analysis/cresols-markett

Key report insights:

  • Global cresols market size will reach USD 474.2 million by the year 2024, growing at 3.4% until 2024.
  • In 2015, meta-cresols market revenue size was in excess of USD 160 million. These are used as a chemical intermediates of synthetic vitamin E. Increasing vitamin E demand owing to enhanced consumer lifestyle and eating habits shall drive industry growth.
  • Para-cresols market is analyzed to witness 3% growth by 2024 owing to its application spectrum across pharmaceuticals, cosmetics, rubber and transformer oil.
  • Chemical intermediates shall witness growth above 3.5% by 2024. Cresols are largely used as a chemical intermediate to produce vitamin E. Increasing vitamin E demand due to its applications in animal feed additive and human dietary supplement along with substantial rise in the chemical industry will further push cresols market size.
  • Asia Pacific will experience highest gains owing to upgrading consumer life food habits, which results in increasing dietary supplement demand and will consequently propelling cresols demand share over the forecast timeframe. Asia Pacific will exhibit CAGR exceeding 3.5% in the same period.
  • In 2015, cresols market share was highly consolidated and key industry players including Henan Hongye Technological Chemical, Lanxess, SABIC, Sasol Phenolics and Atul Ltd, accounted for over half the global demand share. Other industry participants are Rutgers Chemicals, Dakota Gasification and Asahi Kasei Chemicals.

Cresols market research report includes in-depth coverage of the industry, with estimates & forecast in terms of volume in kilo tons & revenue in USD million from 2013 to 2024, for the following segments:

  • Cresols Market By Product Analysis
    • Meta-Cresols
    • Para-Cresols
    • Ortho-Cresols
  • Cresols Market By Application
    • Chemical Intermediates
    • Solvents
    • Preservatives
    • Antioxidants
    • Others

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/789

The above information is provided on a regional and country basis for the following:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • Malaysia
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • GCC

Browse Related Reports:

  • Chemical Indicator Inks Market Size By Sterilization Process (Steam, Ethylene Oxide, Vaporized Hydrogen & Plasma, Formaldehyde), By Printing Process (Flexographic, Rotogravure, Screen), By Product (Solvent-based, Water-based, UV-Cured), By Application (Sterile Bags, Sterile Bottles, IV & Blood Containers, Prefillable Syringes, Thermoformed Trays, Pouches, Tags & Labels, Tapes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, India, Japan, Australia, Indonesia, Malaysia, Brazil, Mexico, South Africa, GCC), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

        https://www.gminsights.com/industry-analysis/...nks-market   

  • Chitosan Market Size By Application (Water Treatment, Biomedicine & Pharmaceuticals, Industrial, Food & Beverage, Cosmetics, Agrochemical), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Russia, Poland, China, India, Japan, Australia, Indonesia, Malaysia, Brazil, Mexico, South Africa, GCC), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

        https://www.gminsights.com/industry-analysis/chitosan-market

Read our insightful industry blogs

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us: Jack Davis Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1 888-689-0688 Email: sales@gminsights.com Web: https://www.gminsights.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 68

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 93

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 54

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
BD's New Liverty™ TIPS Stent: A Game Changer?

Updated Category News Views 75

Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 73

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading